Unclaimed brand
At Greenbrook, we specialize in TMS therapy and Spravato for depression. Antidepressants and talk therapy aren't your only option.
Liking this brand profile? Share this page
Hex Code
Color name
RGB
HSL
CMYK
#48C19E
Puerto Rico
72, 193, 158
163, 49, 52
63, 0, 18, 24
#FFFFFF
White
255, 255, 255
0, 0, 100
0, 0, 0, 0
#463939
Masala
70, 57, 57
0, 10, 25
0, 19, 19, 73
Greenbrook is a depression treatment provider focused on helping patients explore options when antidepressants or talk therapy have not brought the relief they need. Its services include NeuroStar TMS Therapy, an FDA-cleared, non-medication treatment that uses targeted stimulation of brain areas associated with depression and mood regulation, and SPRAVATO® (esketamine), an FDA-approved nasal spray treatment. Greenbrook says TMS can be used on its own or alongside existing medication, while SPRAVATO may be administered alone or with oral antidepressants.
The organization offers consultations, treatment information, patient resources, and locations intended to make care accessible near home, work, or school. Its team also helps patients navigate insurance coverage, paperwork, claims, and appeals; the website notes that coverage varies by plan and location. Visitors can use a short quiz to explore whether TMS may be suitable, read patient stories and FAQs, and learn about the treatment journey.
Greenbrook also provides information for existing patients and healthcare providers, along with company news, careers, and investor relations resources
Company type
Partnership
Year founded
2016
Company size
51-200 employees
The Greenbrook name, logos and brand assets are trademarks of Greenbrook and its affiliates. Brandfetch isn't affiliated with or endorsed by Greenbrook. Their use is subject to Greenbrook's brand guidelines.
